$XTNT

Xtant Medical Holdings, Inc. (XTNT): Submission of Matters to a Vote of Security Holders

Xtant Medical Holdings, Inc. (XTNT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. Xtant Medical Holdings, Inc. (the “Company”) held an Annual Meeting of Stockholders (the “Annual Meeting”) on August 7, 2026. As of the close of business on June 9, 2026, the record date for the Annual Meeting, there

Original reporting
Published Aug 7, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$XTNT
Neutral
high confidence
Mentioned
$XTNT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$XTNTNeutralLow
01

Why it matters

The disclosure confirms quorum and final results for three proposals: election of six directors, ratification of Grant Thornton LLP as independent auditor for 2026, and an advisory vote approving executive compensation.

02

Market read

This is a procedural corporate governance update with no new financial or strategic information, so it is unlikely to drive fresh valuation repricing.

03

What to watch

Traders may instead focus on any concurrent proxy-related developments (not included here), such as activist involvement or changes in director composition beyond the election results.

Relevance 6/10Novelty 2/10Timing: filed after close on Aug 7, 2026, reflecting annual meeting results

Background

The company filed an SEC 8-K under Item 5.07 summarizing matters submitted to a vote of security holders at its Aug 7, 2026 annual meeting.

Company-level read

Ticker impact

$XTNTNeutralHigh confidence
Context

Xtant Medical reported 8-K voting results from its Aug 7, 2026 annual meeting, including director elections and say-on-pay approval.

Expected impact

Low likelihood of a sustained price move solely from these vote tallies.

Evidence & confidence

The filing discloses final vote counts for three proposals (board election, auditor ratification, advisory executive compensation) without any new strategy, financial results, or regulatory action.

Market effects

Minimal, as the disclosure is company-specific governance mechanics.

None indicated.

None indicated.

Counterpoint

If vote outcomes were unusually close or contentious, it could hint at governance dissatisfaction, but the article provides no narrative or threshold triggers beyond the counts.

Key entities

  • Xtant Medical Holdings, Inc.

    NYSE American-listed company filing the 8-K with annual meeting voting results.

  • Grant Thornton LLP

    Independent registered public accounting firm ratified for the year ending Dec 31, 2026.

Related articles

$XTNTMed

Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary

Xtant Medical Holdings reported Q2 2026 revenue headwinds tied to divestitures to Companion Spine and the end of certain license revenue. Biologics softness and amniotic membrane weakness persisted, while 17 new Dilon reps weighed on sales. Full-year 2026 guidance was cut to $99M-$103M; cash fell to $9.9M. Gross margin was 57.9%.

$XTNTHigh

Xtant Medical Holdings, Inc. (XTNT): Results of Operations and Financial Condition

Xtant Medical Holdings, Inc. (XTNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Xtant Medical Reports Second Quarter 2026 Financial Results Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast to

$CVXHighAI 8/10

US expands Venezuela oil push as Chevron prepares project expansion

U.S. President Trump announced an agreement to secure majority control of 65 billion barrels of Venezuela's oil reserves, with Chevron preparing to expand projects. The deal aims to increase U.S. crude supplies and invest in Venezuela's energy sector, though legal and financial details remain unclear. Chevron expects to finalize negotiations for greater control and expansion of its Venezuelan operations.

$HDBMed

HDFC Bank CEO Jagdishan to step down in October as governance pressures mount

HDFC Bank, India's largest private lender, announced CEO Sashidhar Jagdishan will step down in October, not seeking reappointment. This follows governance concerns, regulatory scrutiny, and a 27% stock decline since January. The bank's board previously penalized Jagdishan for business overreach. Investors have also been disappointed by lack of financial gains from the 2023 merger with HDFC Ltd.

$METAMedAI 8/10

US opposition to AI, data centers and social media grows

US public concern over AI, data centers, and social media is rising. Pew Research shows 50% of Americans are more worried than excited about AI. CNBC's Generation Lab survey found low trust in tech CEOs like Dario Amodei, Sam Altman, and Mark Zuckerberg. Data center projects worth $130B faced delays due to local opposition. Meta settled a $17B lawsuit over child safety on Facebook and Instagram.

$WDSMed

Woodside Drops Its Climate Target and Leans Harder on Senegal

Woodside Energy abandoned its long-term Scope 3 climate targets, including a US$5 billion clean-energy investment plan. The company reported a 7% rise in underlying net profit to US$1.33 billion and a 27% increase in statutory net profit to US$1.67 billion. Woodside's Senegalese field, Sangomar, is central to its strategy, with production averaging 99,000 barrels per day. The company is also in a tax arbitration with Senegal's government over a US$68 million reassessment.